chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Info has been received from an RN concerning a 43 month old male who in May, 1994, was vaccinated, SC, with a 0.5 ml dose of varicella virus vaccine live. It was reported by the pt's mother that on 1/3/97, the pt experienced chickenpox. The child developed more than 50 vesicular lesions and a fever. Subsequently, the pt recovered from chickenpox. According to the pt's mother, on 3/1/06, the pt again developed chickenpox characterized by more than 50 vesicular lesions but no fever. Unspecified medical attention was sought. The child has not been seen by a HCP and no diagnostic studies have been done. At the time of this report, the child was said to be recovering and was taking OTC Benadryl. Additional info has been requested. Additional information has been received from the registered nurse on 04-MAY-2006 indicating hat she called the child's mother and has not received a return call or response from her. The nurse, therefore, has no further information at the time of this report.
Fulminant hepatic failure. Unclear if related to booster dose administered on 1/24/22. Hospitalized on 2/9/22 and deceased on 2/14/22.
Upper lip felt swollen/numb, tightening or throat, wheezing, sneezing, prickly feeling in face
Hair loss being blamed on stress but stress levels were same or lower after getting vaccine. Never had issue with stress related female hair loss prior to receiving Moderna Vaccine series.
Myalgia, chills, 98.9    malaise  I am still having the symptoms.
After first dose my period came early (as in that night). After my second dose the next month, I have not had my period since. I have tested multiple times, I am not pregnant. I am not on birth control as I am trying to get pregnant. So this is very distressing to my husband and myself. I have made an appointment with my OB/GYN but he is booked solid and the appointment is not for a few weeks.
Left arm redness, swelling, pruritus 2 days after injection, steroid cream and antihistamines.
COVID disease a long time after Moderna COVID shots; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID disease a long time after Moderna COVID shots) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In August 2022, the patient experienced COVID-19 (COVID disease a long time after Moderna COVID shots). At the time of the report, COVID-19 (COVID disease a long time after Moderna COVID shots) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2022, COVID-19: Positive. On an unknown date, Antibody test: 6.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant information was reported. It was reported that patient wife antibody level was 25000. No treatment information was provided.   Reporter did not allow further contact
Red rash on left arm, by injection site.   Swollen, sore, and itching.   3 1/2 inch by 1 1/2 inch
Patient developed right subconjuctival hemorrhage 3 hours after receiving vaccine. Patient reportedly received no other medication prior to event. Patient was given artificial tears to keep eyes moist. 60 day follwow up states assume yes that pt has recovered.
18 hours post vax, the pt experienced swelling and redness of right thigh, with no fever or tenderness.
Light-headedness, central cyanosis, no loss of consciousness, no local reaction. Same event on previous dose 2 months ago.
Fever; Pain at injection site; This is a spontaneous report from a contactable consumer. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the right arm on 22Apr2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the right arm on 01Apr2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 23:45, the patient experienced fever and pain at injection site. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever and pain at injection site were resolved on an unspecified date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have had ringing, buzzing, hissing and times where it feels as if I have a bubble in my ear and no sound. This started in December and continues until this day. The doctors ran hearing test to rule out hearing loss, I have not lost any hearing. It is periodic, I do not know when it come.
Mother reports child "started screaming and crying" Monday night after shots were administered (Shots were admiministered during AM clinic between 9am and 11am). Mother reports child could only be consoled by holding her "24/7". Mother states child slept poorly Monday and Tuesday night and did have a low grade fever Tuesday. By Friday 3/16, Mother reports child continues with crying during the day but will sleep at night. Mother states no previous reactions to immunizations in the past (this is the first time the child has, however, had the MMRV vaccine). Mother states child is also teething (cutting 3 top teeth) and has a HX of ear infection x2 in the past and does sleep poorly with same per Mom. On 3/16 Mother advised to consider having child assessed by Dr. and report results to local health dept. On Monday 3/19, I did leave a message for Mom to call the LHD. On 3/20, I did call Mom again to check on status of child. Mom states has not yet taken child to doctor, but plans to do so "in the next couple of days". Mom states child's fussiness continues.
On 12/1/98, pt was vax w/ 3rd dose of Pneumovax.On 12/3/98, pt dvlped headache & nausea.Later that day,pt's neck became stiff w/ pain radiating to her back.Pt was hospitalized.
She received 1st dose of Covid vaccine and then tested positive for Covid.; She received 1st dose of Covid vaccine and then tested positive for Covid.; This is a spontaneous report from a contactable other health professional from a Pfizer-sponsored program Pfizer First Connect.  A female elderly patient (Grandmother, 80 or older) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received 1st dose of covid vaccine and then tested positive for covid on 12Jan2021. The patient underwent lab tests and procedures which included Covid: positive on 12Jan2021. The reporter's grandmother (female, caller stated age is 80 or older) received the vaccine 3 weeks ago and was scheduled to get the vaccine tomorrow but tested positive for covid on 12Jan2021. The reporter was wondering whether she could get the 2nd dose in this case. She's asymptomatic, not sure when she came down with it.  She resided in a Senior care facility. They would have (Pharmacy name) coming tomorrow to get the vaccine. They stated she won't be getting it. The reporter was asked whether it would lose effectiveness if wait and whether the efficacy would go down If wait longer to get the 2nd dose. The outcome of events was unknown.  Information on the batch number and lot number has been requested.
Hives and itchy rash all over body on day 15 & 16 after the 4th dose.
Presented to clinic 11/16/10 with lesion on hand, foot, & mouth. Worsened in 24 hours and referred to Dermatology at Med Center. Treated with antihistamine & Acyclovir.  Dermatologist notes that there may have been a temporal relationship between the erythema multiforme and the flu immunization.  Patient fit for full duty 12/03/10.
Chest Pain Chest Tightness Lightheadedness Headache Pressure in Head Cough Swelling in Ankles Leg Weakness Tiredness  starting from day after shot until today.
Delayed injection site reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Delayed injection site reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Delayed injection site reaction). At the time of the report, VACCINATION SITE REACTION (Delayed injection site reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a delayed injection site reaction Treatment information was not provided. Concomitant product information was not provided
the spot itched like crazy; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced "the spot itched like crazy" on an unspecified date. The outcome of the event was unknown.  Information about lot/batch has been requested.
more than 35 days have passed between doses; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (more than 35 days have passed between doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 35 days have passed between doses). At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 35 days have passed between doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
never reconstituted it, adminsted diluent; never reconstituted it, adminsted diluent; This case was reported by a physician via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 7th June 2022, the patient received Menveo. On 7th June 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 1-JUL-2022 Reporter's comment: The registered nurse drew diluent and never reconstituted it and administered to the patient. Additional supportive information As patient received only diluent of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
SEVERE HEADACHE/HURTING; NOT REALLY LOOSE STOOL BUT ALMOST GETTING THERE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy to wheat, and celiac. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A expiry: UNKNOWN) dose was not reported, administered on 09-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-SEP-2021, the patient experienced severe headache/hurting. On 09-SEP-2021, the patient experienced not really loose stool but almost getting there. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe headache/hurting, and not really loose stool but almost getting there. This report was non-serious.
after getting the 2nd dose, he had experienced TIA (Transient Ischaemic Attack) which he went to the ER and has been diagnosed with a DVT (Deep Vein Thrombosis).; after getting the 2nd dose, he had experienced TIA (Transient Ischaemic Attack) which he went to the ER and has been diagnosed with a DVT (Deep Vein Thrombosis).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old male patient received bnt162b2 (COMIRNATY), administration date 03Aug2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 13Jul2021, for COVID-19 immunization. The following information was reported: DEEP VEIN THROMBOSIS (medically significant), TRANSIENT ISCHAEMIC ATTACK (medically significant), outcome "unknown" and all described as "after getting the 2nd dose, he had experienced TIA (Transient Ischaemic Attack) which he went to the ER and has been diagnosed with a DVT (Deep Vein Thrombosis).". The event "after getting the 2nd dose, he had experienced tia (transient ischaemic attack) which he went to the er and has been diagnosed with a dvt (deep vein thrombosis)." and "after getting the 2nd dose, he had experienced tia (transient ischaemic attack) which he went to the er and has been diagnosed with a dvt (deep vein thrombosis)." was evaluated at the emergency room visit.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Light fever, chills, headache, red, raised injection site swelling and general swelling of entire arm (predominantly upper arm down to elbow. Adverse effect lasted 2 weeks.
Information has been received from a nurse concerning an 18 year old female who, on an unspecified date, was vaccinated intramuscularly with a first dose of HPV. Subsequently, on an unspecified date, the patient developed a rash. The patient did not seek medical attention. Subsequently, on an unspecified date, the patient recovered. No product quality complaint was involved. Additional information is not expected.
I had a slighter sore arm after receiving the vaccine. I tested positive for COVID-19 on 07/04/2022. My symptoms started on 07/03/2022 with minor aching and coughing. I did not have a temperature. I went to an urgent care center to be checked out. They gave me an infusion (don't remember the name of the medication). Prior to going to the urgent care center, I took TYLENOL for my symptoms
My skin suddenly appears to be very vulnerable to "abrasion". I had a mosquito bite on my right wrist, I gave it a mild scratch, and all of a sudden I had what appeared to be light cuts on the skin I scratched (As if I had thrust my hand into a thorny bush). Something similar has happened on my left thumb and left arm. I have had mosquito bites regularly, and scratch them, this is absolutely unusual. Since my first vaccine shot for some reason my skin has become extremely sensitive to scratching, I have all of these light abrasions on my arms (like I said they look like a thorn sliced them).
could not  urinate; no sleep; lost 9 pounds; pulse rate is high in the 90s; could not defecate; constant pain in the colon on the left side, pain in my intestines; This spontaneous case was reported by a consumer and describes the occurrence of URINARY RETENTION (could not  urinate) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URINARY RETENTION (could not  urinate) (seriousness criterion medically significant), INSOMNIA (no sleep), WEIGHT DECREASED (lost 9 pounds), HEART RATE INCREASED (pulse rate is high in the 90s), DYSCHEZIA (could not defecate) and ABDOMINAL PAIN (constant pain in the colon on the left side, pain in my intestines). At the time of the report, URINARY RETENTION (could not  urinate), INSOMNIA (no sleep), WEIGHT DECREASED (lost 9 pounds), HEART RATE INCREASED (pulse rate is high in the 90s), DYSCHEZIA (could not defecate) and ABDOMINAL PAIN (constant pain in the colon on the left side, pain in my intestines) outcome was unknown.            The patient used blood thinners as concomitant medication.  Patient states she took laxatives and other over-the-medications as treatment.  Action taken with mRNA-1273 in response to the event was not applicable.   Company Comment: This case concerns a 73-year-old female with a serious unexpected event of urinary retention, and non-serious unexpected dyschezia, abdominal pain, weight decreased and insomnia. Event onset with unknown latency after second dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 73-year-old female with a serious unexpected event of urinary retention, and nonserious unexpected dyschezia, abdominal pain, weight decreased and insomnia. Event onset with unknown latency after second dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Inbound call from HCP reporting a 1 month old was inadvertently administered a VAQTA instead of a hepatitis B vaccine.; No additional AE details or PQC.; This spontaneous report was received from a registered nurse and refers to an 1-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.   On 13-SEP-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, 0.5 milliliter, lot #W015191, expiration date: 27-OCT-2023 (route of administration were not provided) instead of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) reported as hepatitis B vaccine (strength, dose, lot #, expiration date and route of administration were not provided) for prophylaxis (Wrong product administered). No adverse events were reported (No adverse event).
Prolonged tachycardia. Heart rate was staying consistently over 100, beats per minute, even at rest. Heart rate up to 180. Emergency room visits, chest X-rays, blood work, had to follow up with a specialists, I wore a heart monitor over a Month, I was off work for a month due to the high heart rate, shortness of breath, and weakness it caused
Large area of red rash--itchy, painful--on both upper arms, upper thighs, abdomen (below the navel) front and sides; lesser irritation on back of neck.
Patient developed red dots surrounding eyes after clinic visit  on 11/3/00 and returned to clinic that day with mother. Fine petechiae were noted to left periorbital region, to skin immediately below eyebrow and to external lateral side and bottom of left eye. No edema, pruritus, or respiratory problems were observed. The patient was happy, alert, smiling and in no acute distress. Per mother, the dots had faded by the morning of 11/4/00.
Diarrhea; Headache; Arm soreness; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is the 3rd of 6 reports. A 45-year-old female patient received a single dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine) on 29Dec2020 for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. After vaccination, on 29Dec2020, the patient had arm soreness and it lasted a few hours. The patient took Tylenol and was fine. She also developed diarrhea and headache, and her symptoms hit her all of a sudden late afternoon on 04Jan2021. No treatment was received. She woke up in the morning of 05Jan2021 and it was all gone. She had a COVID test on 05Jan2021 and it was negative. The patient recovered from the arm soreness on 29Dec2020 and recovered from diarrhea and vomiting on 05Jan2021. The events were considered related to the vaccine. Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021006274 same reporter/ drug , different patient /AE.
19 month old developed large shingles rash covering entirety of right thigh from varicella vaccine approx 6 months after vaccine.
I walked over to another chair & sat down to be monitored for 15 minutes after injection. Within a minute a tasted a metallic taste  & felt tingly in my chest i ignored for like another minute then i felt my heart pounding i notified staff. My blood pressure was checked 180/108 heart rate 103(average bp 110/70 hr 68). i was given benadryl 50 mg by mouth. I was confused as why i would taste medicine injection given properly shouldnt have entered my bloodstream so quickly. I was monitored for an additional 15 minutes w repeated bp/hr checks at 30 minutes bp still elevated at 160/90 hr 78 i didnt have tingling in chest didnt have pounding in chest bp still elevated but had lowered some.my husband present firefighter/ emt.i had reaction to 5fu chemo med and had same with elevated hr & bp but worse had to receive iv steroids& this was after 3 months of chemo. My bp & hr also ekevate if i eat gluten. I am aware being an RN and having had previos reactions that the second shot msy cause a more ssvere reaction.i will not be taking any further covid vaccine until i know what caused this reaction. My son took his vaccine at same location without incident that day he has no allergies. I only felt heache & slight nausea feeling flush approximately 2 hours after i left place of vaccination.no other problems since.
S/P Covid vaccine #1, no prior allergy history.  15 min after vaccine patient developed chest tightness/wheezing.  given Zyrtec 10mg and sent to ER for evaluation.
Primary Care Nurse Practitioner asked patient if he received his Pfizer booster shot (he qualifies based on his age). There was no record in his chart of a booster dose and he informed the NP that hadn't received booster. NP informed RN to give booster and it was given.  Patient did not report to the RN prior to giving the shot that he already received the booster. Patient does have a history of dementia. After visit, his wife called and informed RN that patient had already received a booster dose on 9/25/21 at pharmacy. Explained possible side effects and to inform his PCP NP if he has any side effects other than pain/swelling/redness at the injection site.
Rash at injection site developed a couple days later -> rash traveled down the arm to the fore arm. The rash red, warm, uncomfortable. Pt reported to MD 4-5 days later. Pt state MD gave oral antibiotic and BENADRYL OTC.